Standout Papers

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia 2013 2026 2017 2021 2.6k
  1. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia (2013)
    Stephan A. Grupp, Michael Kalos et al. New England Journal of Medicine
  2. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy (2019)
    Albert M. Maguire, Stephen R. Russell et al. Ophthalmology

Immediate Impact

13 by Nobel laureates 25 from Science/Nature 167 standout
Sub-graph 1 of 16

Citing Papers

CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout
17 intermediate papers

Works of J. Fraser Wright being referenced

Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery
2018
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
2012
and 2 more

Author Peers

Author Last Decade Papers Cites
J. Fraser Wright 4332 3717 3247 89 7.7k
Federico Mingozzi 6949 6746 2534 122 10.0k
W. French Anderson 7229 5189 2226 186 11.4k
Roland W. Herzog 8014 8356 3856 214 12.5k
Christine Kinnon 3315 2873 1278 117 7.1k
Michel Perricaudet 7889 6736 3116 172 13.3k
Narendra Chirmule 4064 3795 1255 114 7.6k
Elio F. Vanin 4660 2251 2059 92 7.2k
Boris Fehse 5013 2776 2649 246 9.0k
Rob C. Hoeben 3902 3681 1685 206 7.5k
J. Thomas Parsons 7090 1007 1556 75 13.3k

All Works

Loading papers...

Rankless by CCL
2026